Regional radiopharmacy hubs and harmonised transport rules for short-lived isotopes
Radioactive cancer drugs decay while they travel and get stuck at borders. Regional production and simpler transport rules would get more doses to patients on time.
Radioligand therapies are often labelled centrally and shipped internationally, losing activity to decay and to customs delays; dangerous goods rules differ by country and carrier. The proposal is a network of regional GMP radiopharmacies (one per few million population) receiving bulk isotope and cold kits, labelling on demand, and delivering same-day, combined with an IAEA-brokered harmonisation of Class 7 transport paperwork and pre-clearance for medical isotopes at major airports.
- Manufacturing cost and time for living and radioactive medicines · Cell therapies take weeks to make for one patient and cost hundreds of thousands of dollars. Isotopes run short.
- Most of the world has almost no cancer care · Seven in ten cancer deaths happen in low- and middle-income countries, where radiotherapy, pathology, surgery and drugs are scarce.
Pages like this
not linked directly; found by shared links- IdeaBuild Western ytterbium-176 enrichment so lutetium-177 has more than one supplier
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters), Manufacturing cost and time for living and radioactive medicines.
- IdeaA coordinated reserve and shared schedule for the world's medical isotope reactors
Shares Radioligand therapy (beta emitters), Manufacturing cost and time for living and radioactive medicines, Most of the world has almost no cancer care.
- InstitutionChulabhorn Hospital / Chulabhorn Royal Academy
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).
- InstitutionTUM Klinikum rechts der Isar / CCC München
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).
- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).
- CompanyClarity Pharmaceuticals
- InstitutionInselspital, Bern University Hospital / University Cancer Center Inselspital
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).